Intranasal nanobubbles and low-frequency ultrasound enable targeted delivery of therapeutics to the brain: A novel non-invasive strategy for neurological disorders

Puntos clave

• Targeted delivery of therapeutics significantly improves with the use of intranasal nanobubbles and low-frequency ultrasound.
• Key evidence demonstrates enhanced brain uptake of therapeutics by 75% using this innovative approach.
• Analysis of therapeutic strategies incorporates non-invasive intranasal delivery methods alongside ultrasound technology.
• This method may enable effective treatments for neurological disorders, suggesting a transformative pathway in neurotherapeutics.